Organigram Holdings (OGI) | Financial Analysis & Statements
Organigram Holdings Inc. Micro-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
63.5M
Gross Profit
23.3M
36.69%
Operating Income
-3.4M
-5.38%
Net Income
20.0M
31.43%
EPS (Diluted)
$0.15
Balance Sheet Metrics
Total Assets
530.7M
Total Liabilities
161.2M
Shareholders Equity
369.5M
Debt to Equity
0.44
Cash Flow Metrics
Operating Cash Flow
30.8M
Free Cash Flow
-18.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Organigram Holdings Income Statement From 2020 to 2025
| Metric | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 259.2M | 116.0M | 145.8M | 79.2M | 86.8M |
| Cost of Goods Sold | 169.0M | 81.5M | 114.2M | 107.6M | 143.3M |
| Gross Profit | 90.2M | 34.5M | 31.6M | -28.4M | -56.5M |
| Gross Margin % | 34.8% | 29.7% | 21.7% | -35.9% | -65.1% |
| Operating Expenses | |||||
| Research & Development | 10.9M | 8.1M | 6.0M | 3.6M | 1.3M |
| Selling, General & Administrative | 86.9M | 49.5M | 59.2M | 46.5M | 46.5M |
| Other Operating Expenses | - | - | -154.0K | -8.1M | -7.9M |
| Total Operating Expenses | 97.8M | 57.6M | 65.0M | 42.0M | 39.9M |
| Operating Income | -15.3M | -25.9M | -38.8M | -72.8M | -97.9M |
| Operating Margin % | -5.9% | -22.3% | -26.6% | -92.0% | -112.7% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | - | - | 429.0K | 3.0M | 6.0M |
| Other Non-Operating Income | -23.2M | -7.1M | 24.8M | -54.9M | -42.8M |
| Pre-tax Income | -38.5M | -33.0M | -14.4M | -130.7M | -146.6M |
| Income Tax | -13.8M | 0 | -88.0K | 0 | -10.5M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -24.8M | -33.0M | -14.3M | -130.7M | -136.2M |
| Net Margin % | -9.6% | -28.4% | -9.8% | -165.1% | -156.9% |
| Key Metrics | |||||
| EBITDA | 25.9M | -14.4M | -15.2M | -42.9M | -81.1M |
| EPS (Basic) | $-0.19 | $-0.48 | $-0.19 | $-2.04 | $-3.16 |
| EPS (Diluted) | $-0.19 | $-0.48 | $-0.19 | $-2.04 | $-3.16 |
| Basic Shares Outstanding | 127674167 | 69181464 | 112213617 | 93035563 | 70656142 |
| Diluted Shares Outstanding | 127674167 | 69181464 | 112213617 | 93035563 | 70656142 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Organigram Holdings Balance Sheet From 2020 to 2025
| Metric | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 28.2M | 77.5M | 68.5M | 55.4M | 24.6M |
| Short-term Investments | 826.0K | 596.0K | 30.4M | 128.5M | 50.1M |
| Accounts Receivable | 63.6M | 23.7M | 43.9M | 20.2M | 11.1M |
| Inventory | 124.0M | 59.9M | 68.3M | 48.8M | 71.8M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 284.9M | 190.4M | 221.6M | 260.6M | 170.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 213.6M | 136.3M | 180.8M | 155.0M | 146.1M |
| Goodwill | 153.6M | 5.9M | 98.2M | 31.4M | 1.8M |
| Intangible Assets | 48.5M | 5.9M | 14.3M | 2.7M | 1.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 3.8M | 429.1K | 32.4M | 35.4M | 8.7M |
| Total Non-Current Assets | 277.3M | 105.7M | 355.5M | 293.4M | 264.9M |
| Total Assets | 562.2M | 296.1M | 577.1M | 554.0M | 435.1M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 89.2M | 34.2M | 40.9M | 19.0M | 17.5M |
| Short-term Debt | 1.0M | 788.4K | 996.0K | 1.1M | 11.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 35.6M | 3.7M | 7.0M | 3.5M | - |
| Total Current Liabilities | 126.2M | 38.7M | 55.3M | 26.3M | 29.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 7.7M | 2.4M | 2.4M | 4.9M | 106.3M |
| Deferred Tax Liabilities | - | - | 3.6M | 0 | 0 |
| Other Non-Current Liabilities | 5.0M | - | 2.9M | 5.5M | 231.0K |
| Total Non-Current Liabilities | 86.9M | 35.2M | 13.8M | 47.9M | 106.5M |
| Total Liabilities | 213.1M | 74.0M | 69.0M | 74.2M | 135.6M |
| Equity | |||||
| Common Stock | 919.9M | 619.2M | 769.7M | 730.8M | 420.7M |
| Retained Earnings | -608.7M | -423.9M | -289.9M | -275.6M | -144.9M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 349.1M | 222.1M | 508.1M | 479.8M | 299.5M |
| Key Metrics | |||||
| Total Debt | 8.8M | 3.2M | 3.4M | 5.9M | 117.9M |
| Working Capital | 158.7M | 151.7M | 166.3M | 234.3M | 141.1M |
Balance Sheet Composition
Organigram Holdings Cash Flow Statement From 2020 to 2025
| Metric | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -24.8M | -33.0M | -14.3M | -130.7M | -136.2M |
| Depreciation & Amortization | 18.0M | 8.8M | 24.9M | 31.0M | 18.0M |
| Stock-Based Compensation | 4.2M | 5.2M | 5.1M | 3.9M | 7.8M |
| Working Capital Changes | -15.3M | -8.8M | -47.2M | 14.5M | 29.0M |
| Operating Cash Flow | -47.1M | -26.4M | -38.6M | -70.8M | -89.6M |
| Investing Activities | |||||
| Capital Expenditures | -16.9M | -3.2M | -48.7M | -11.8M | -77.2M |
| Acquisitions | -65.6M | - | -11.1M | -2.5M | 0 |
| Investment Purchases | -1.0M | -21.2M | -15.0M | -120.0M | -50.0M |
| Investment Sales | 2.5M | 2.6M | 113.1M | 50.1M | 135.0K |
| Investing Cash Flow | -81.0M | -27.7M | 44.1M | -114.6M | -136.8M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | 0 | 0 | 0 |
| Debt Issuance | - | - | - | 0 | 64.3M |
| Debt Repayment | -1.9M | -570.6K | -1.0M | -116.4M | -952.0K |
| Financing Cash Flow | 39.3M | 78.2M | -1.1M | 168.5M | 163.3M |
| Free Cash Flow | -24.6M | -1.1M | -85.0M | -40.9M | -123.8M |
| Net Change in Cash | -88.8M | 24.1M | 4.4M | -16.9M | -63.0M |
Cash Flow Trend
Organigram Holdings Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.05
Forward P/E
79.72
Price to Book
0.72
Price to Sales
0.72
PEG Ratio
-0.08
Profitability Ratios
Profit Margin
6.49%
Operating Margin
-5.38%
Return on Equity
4.64%
Return on Assets
-1.48%
Financial Health
Current Ratio
2.73
Debt to Equity
1.99
Beta
1.87
Per Share Data
EPS (TTM)
$0.11
Book Value per Share
$1.99
Revenue per Share
$2.11
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| OGI | 203.2M | 13.05 | 0.72 | 4.64% | 6.49% | 1.99 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Aurora Cannabis | 200.4M | 20.75 | 0.49 | -15.51% | -22.51% | 17.79 |
| Anika Therapeutics | 221.7M | - | 1.48 | -6.71% | -9.64% | 18.30 |
| Lifecore Biomedical | 184.4M | 56.23 | -17.45 | 312.34% | -23.78% | 414.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






